FIELD: medicine, endocrinology. SUBSTANCE: invention relates to analogs of insulin modified at position 29 of its chain or at other positions and showing modified physico-chemical and pharmacokinetic properties. EFFECT: enhanced effectiveness of insulin analogs. 7 cl, 5 tbl, 31 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING OF ZYMOGENIC FORM OF HUMAN C-PROTEIN | 1989 |
|
RU2018535C1 |
| METHOD OF PREPARING OF HUMAN RECOMBINANT ACTIVATED PROTEIN C | 0 |
|
SU1830081A3 |
| DIPEPTIDYLAMINOPEPTIDASE AND METHOD OF ENZYMATIC SPLITTING OFF N-TERMINAL DIPEPTIDES MET-TYR, MET-ARG OR MET-ASP FROM THE POLYPEPTIDE SEQUENCE | 1993 |
|
RU2096455C1 |
| METHOD OF EXPRESSION OF DACS/DAOCS ACTIVITY IN ESCHERICHIA COLI CELLS | 0 |
|
SU1838413A3 |
| METHOD FOR CONSTRUCTING OF RECOMBINANT PLASMID DNA, ENCODING ENZYME DEACET-OXYCEPHALOSPORINE C- SYNTHETASE/DEACETYLCEPHALOSPORINE C-SYNTHETASE | 0 |
|
SU1739856A3 |
| ACYLATED INSULIN ANALOGS | 1995 |
|
RU2160118C2 |
| METHOD OF TYLOSINE PREPARING | 1987 |
|
RU2043416C1 |
| METHOD OF SELECTIVE ACYLATION OF PROINSULIN, INSULIN OR INSULIN ANALOG HAVING FREE ε- AND α-AMINOGROUPS | 1995 |
|
RU2155773C2 |
| COMPLEX OF INSULIN ANALOG AND PROTAMINE, METHOD OF PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD OF DIABETIC TREATMENT | 1995 |
|
RU2154494C2 |
| METHOD FOR CONSTRUCTION OF RECOMBINANT PLASMID DNA, ENCODING HUMAN ZYMOGEN C | 0 |
|
SU1739854A3 |
